Vikas Lifecare

Who are the top shareholders of the Vikas Lifecare?

The top shareholders of Vikas Lifecare include promoter Vikas Garg with 13.1%, public shareholder Sylph Technologies at 3.1%, and individual investors holding 73.79%. There are also 18 Foreign Institutional Investors with a combined 0.46% stake, and no mutual funds currently hold shares.

The top shareholders of Vikas Lifecare include Vikas Garg, who is the promoter with the highest holding at 13.1%. The highest public shareholder is Sylph Technologies, holding 3.1%. Additionally, individual investors collectively hold a significant portion of the shares at 73.79%. The company also has 18 Foreign Institutional Investors (FIIs) with a combined holding of 0.46%. Notably, there are no mutual funds currently holding shares in the company.

how big is Vikas Lifecare?

As of Jun 06, Vikas Lifecare Ltd has a market capitalization of 473.71 Cr, with net sales of 480.02 Cr and a net profit of -10.14 Cr for the latest four quarters. Shareholder's funds are 476.69 Cr, and total assets amount to 554.70 Cr as of Mar'24.

Market Cap: As of Jun 06, Vikas Lifecare Ltd has a market capitalization of 473.71 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Vikas Lifecare reported net sales of 480.02 Cr and a net profit of -10.14 Cr. This data is on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: The balance sheet data is also on a Consolidated basis for the latest annual period ending in Mar'24. Shareholder's funds are reported at 476.69 Cr, while total assets amount to 554.70 Cr.

Has Vikas Lifecare declared dividend?

No Dividend History Available

Is Vikas Lifecare overvalued or undervalued?

As of July 22, 2024, Vikas Lifecare is considered overvalued and risky, with a negative PE ratio of -46.72 and an EV to EBITDA of -25.23, significantly underperforming against the Sensex with a year-to-date return of -38.77%.

As of 22 July 2024, the valuation grade for Vikas Lifecare has moved from very expensive to risky, indicating a significant shift in its market perception. The company is currently considered overvalued. Key ratios reveal a PE ratio of -46.72, an EV to EBITDA of -25.23, and a Price to Book Value of 0.89, which highlight the underlying financial challenges the company faces.<BR><BR>In comparison to its peers, Vikas Lifecare's valuation metrics are concerning, particularly when contrasted with industry standards. For instance, its PE ratio is significantly negative, while the EV to EBITDA ratio also reflects a troubling trend. Notably, the company has underperformed against the Sensex, with a year-to-date return of -38.77% compared to the Sensex's positive 5.56%. This performance further reinforces the notion that Vikas Lifecare is currently overvalued in the market.

What is the technical trend for Vikas Lifecare?

As of June 4, 2025, Vikas Lifecare's technical trend is bearish, supported by daily moving averages and Bollinger Bands, despite a mildly bullish weekly MACD, indicating a prevailing bearish market sentiment.

As of 4 June 2025, the technical trend for Vikas Lifecare has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength indicated by the daily moving averages and Bollinger Bands both signaling bearish trends. The weekly MACD shows a mildly bullish signal, but this is countered by the monthly MACD and KST both being bearish. The Dow Theory indicates a mildly bearish trend on the weekly timeframe, while the monthly shows no trend. Overall, the indicators suggest a prevailing bearish sentiment in the market for Vikas Lifecare.

Who are the peers of the Vikas Lifecare?

Vikas Lifecare's peers include Oswal Agro Mills, Veritas (India), and Mehai Technology, among others. Oswal Agro Mills and Mehai Technology show excellent management and growth, while Vikas Lifecare has a 1-year return of -50.39%, better than Veritas (India) but worse than Mehai Technology's 398.50%.

Peers: The peers of Vikas Lifecare are Oswal Agro Mills, Veritas (India), S T C, Mehai Technology, Kothari Products, Sakuma Exports, Riddhi Siddhi Gl, Balgopal Commer., and Northern Spirits.<BR><BR>Quality Snapshot: Excellent management risk is observed at Oswal Agro Mills and Mehai Technology, while Average management risk is found at Sakuma Exports, Riddhi Siddhi Gl, Balgopal Commer., and Northern Spirits, and the rest have Below Average management risk. Excellent growth is seen at Oswal Agro Mills and Mehai Technology, while Average growth is noted at Sakuma Exports, and the rest have Below Average growth. Excellent capital structure is present at Oswal Agro Mills and Veritas (India), while Good capital structure is found at Sakuma Exports and Balgopal Commer., and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mehai Technology at 398.50%, while Veritas (India) has the lowest at -66.05%. Vikas Lifecare's 1-year return is -50.39%, which is higher than Veritas (India) but lower than Mehai Technology. Additionally, the six-month return is negative for Veritas (India), Mehai Technology, Sakuma Exports, and Vikas Lifecare.

Who are in the management team of Vikas Lifecare?

As of March 2022, the management team of Vikas Lifecare includes Arvind Gupta (CFO), Anil Kumar, Ruby Bansal, Parul Rai (Company Secretary), Vijay Kumar Sharma (CEO), Sundeep Kumar Dhawan (Managing Director), Richa Sharma, and Chandan Kumar (CFO). Each member plays a key role in the company's governance and operations.

As of March 2022, the management team of Vikas Lifecare includes the following individuals:<BR><BR>1. Arvind Gupta - Director (Finance) & CFO<BR>2. Anil Kumar - Independent Director<BR>3. Ruby Bansal - Independent Director<BR>4. Parul Rai - Company Secretary & Compliance Officer<BR>5. Vijay Kumar Sharma - Director & Chief Executive Officer<BR>6. Sundeep Kumar Dhawan - Managing Director<BR>7. Richa Sharma - Independent Director<BR>8. Chandan Kumar - Director & CFO<BR><BR>Each member holds a specific role that contributes to the governance and operational management of the company.

What does Vikas Lifecare do?

Vikas Lifecare Ltd specializes in recycling plastic waste and manufacturing polymer compounds, operating within the Micro Cap market. As of March 2025, it reported net sales of 1,352 Cr and a net loss of 29 Cr, with a market cap of INR 479 Cr.

Overview:<BR>Vikas Lifecare Ltd operates in the recycling of plastic waste and the trading and manufacturing of polymer compounds, positioned in the Trading & Distributors industry within the Micro Cap market-cap bracket.<BR><BR>History:<BR>The company was originally incorporated as Vikas Multicorp Limited in 1995 and changed its name to Vikas Lifecare Limited on April 09, 2021. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 1,352 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -29 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 479 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A (Loss Making)<BR>- Industry P/E: 19<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.13<BR>- Return on Equity: -1.91%<BR>- Price to Book: 0.89<BR><BR>Contact Details:<BR>- Address: G 1 34/1 East Punjabi Bagh, Vikas Apartments, New Delhi, Delhi: 110026<BR>- Tel: 91-011-40450110<BR>- Email: info@vikasmulticorp.com<BR>- Website: http://www.vikaslifecarelimited.com

Are Vikas Lifecare latest results good or bad?

Vikas Lifecare's latest results are disappointing, with a 23% decline in net sales to Rs 92.38 crore and a loss of Rs 3.96 crore in Profit After Tax, leading to a 'Strong Sell' rating by MarketsMOJO due to ongoing financial difficulties.

Vikas Lifecare's latest results are quite disappointing. For the quarter ending June 2025, the company reported net sales of Rs 92.38 crore, which is a significant decline of 23.0% compared to the average net sales of Rs 120.01 crore over the previous four quarters. This indicates a challenging sales environment.<BR><BR>Additionally, the company faced a loss of Rs 3.96 crore in Profit After Tax (PAT), which is a 56.2% decline from the average loss of Rs -2.54 crore in the prior four quarters. This trend suggests ongoing financial difficulties.<BR><BR>Moreover, interest expenses have increased by 36.03% over the preceding nine months, reaching Rs 4.04 crore, indicating higher borrowings that further complicate the financial situation. Overall, these results have led to a 'Strong Sell' rating by MarketsMOJO, reflecting a negative outlook for the company.

How has been the historical performance of Vikas Lifecare?

Vikas Lifecare has experienced fluctuating financial performance, with net sales increasing to 480.02 Cr in March 2025, but profitability declining significantly, resulting in a net loss of -10.61 Cr. Despite growth in total assets, cash flow from operations has worsened, indicating ongoing financial challenges.

Answer:<BR>The historical performance of Vikas Lifecare shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Vikas Lifecare's net sales have generally increased, reaching 480.02 Cr in March 2025 from 445.75 Cr in March 2024, although it slightly decreased from 476.05 Cr in March 2023. The total operating income followed a similar trend, peaking at 480.02 Cr in March 2025. However, the total expenditure has also risen, amounting to 501.62 Cr in March 2025, which has led to an operating profit (PBDIT) of 4.36 Cr, a decline from 30.49 Cr in the previous year. The company reported a profit before tax of -6.95 Cr in March 2025, down from 17.58 Cr in March 2024, resulting in a profit after tax of -5.00 Cr. The consolidated net profit also fell to -10.61 Cr in March 2025 from 14.03 Cr in March 2024. The total assets of Vikas Lifecare increased to 724.76 Cr in March 2025, up from 554.70 Cr in March 2024, while total liabilities rose to 724.76 Cr from 554.70 Cr in the same period. Cash flow from operating activities showed a negative trend, with -222.00 Cr in March 2025 compared to -41.00 Cr in March 2024, indicating challenges in cash generation. Overall, while Vikas Lifecare has seen growth in sales and assets, profitability has been inconsistent, reflecting a complex financial landscape.

When is the next results date for Vikas Lifecare Ltd?

The next results date for Vikas Lifecare Ltd is February 7, 2026.

The next results date for Vikas Lifecare Ltd is scheduled for February 7, 2026.

Should I buy, sell or hold Vikas Lifecare Ltd?

Why is Vikas Lifecare Ltd falling/rising?

As of 17-Mar, Vikas Lifecare Ltd's stock price is Rs. 1.25, reflecting a 0.79% decrease and a significant decline of 56.90% over the past year. The company shows weak fundamentals, with concerning debt servicing ability and disappointing recent financial results, indicating a precarious stock position.

As of 17-Mar, Vikas Lifecare Ltd's stock price is falling, currently at Rs. 1.25, which reflects a decrease of Rs. 0.01 or 0.79%. The stock has been on a downward trend, having lost 6.02% over the last four days and is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. <BR><BR>The company has recently hit a new 52-week low of Rs. 1.23, indicating significant weakness in its stock performance. Over the past month, the stock has declined by 22.84%, and year-to-date, it has fallen 29.38%. In the last year, the stock has experienced a staggering drop of 56.90%, while the broader market, represented by the Sensex, has gained 2.56% during the same period.<BR><BR>Financially, Vikas Lifecare Ltd has shown weak long-term fundamentals, as it has not declared any results in the last six months. The company's ability to service its debt is concerning, with a negative EBIT to Interest ratio of -0.77, and it has reported a low Return on Equity of 1.43%. Recent quarterly results have also been disappointing, with net sales falling by 23.0% and a significant drop in profit after tax of 56.2% compared to previous averages.<BR><BR>Moreover, the stock's performance has been below par both in the long term and near term, underperforming the BSE500 index over the last three years, one year, and three months. Although there has been a rise in investor participation, with delivery volume increasing by 49.86% against the 5-day average, the overall negative financial indicators and consistent price declines suggest that the stock is in a precarious position, leading to its current falling price trend.

Why is Vikas Lifecare Ltd falling/rising?

As of 18-Mar, Vikas Lifecare Ltd's stock price is rising to 1.33, marking a 6.4% increase after a trend reversal. However, the company faces long-term challenges, including weak debt servicing ability and low profitability, which may impact future performance.

As of 18-Mar, Vikas Lifecare Ltd's stock price is rising, currently at 1.33, reflecting a change of 0.08 or 6.4% increase. This upward movement follows a trend reversal after four consecutive days of decline. The stock has outperformed its sector by 2.95%, indicating a relative strength compared to its peers. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 13.75% against the five-day average, suggesting growing interest in the stock.<BR><BR>Despite this positive short-term performance, the company faces significant long-term challenges. It has not declared results in the last six months, and its ability to service debt is weak, as indicated by a poor EBIT to Interest ratio of -0.77. The company's financial performance has also been concerning, with a return on equity of only 1.43%, reflecting low profitability. Furthermore, recent negative results show a substantial decline in net sales and profit after tax, alongside an increase in interest expenses.<BR><BR>Overall, while the stock is experiencing a short-term rise, the underlying fundamentals indicate a precarious situation for Vikas Lifecare Ltd, which may affect its future performance.

Why is Vikas Lifecare Ltd falling/rising?

As of 19-Mar, Vikas Lifecare Ltd's stock price is at 1.31, reflecting a decline of 1.5%. Despite a recent increase in investor participation, the stock has significantly underperformed over various periods, indicating a longer-term downward trend.

As of 19-Mar, Vikas Lifecare Ltd's stock price is falling, currently at 1.31, which reflects a change of -0.02 or -1.5%. The stock has underperformed significantly over various periods, with a year-to-date decline of 25.99% compared to a 12.92% drop in the benchmark Sensex. Over the past year, the stock has decreased by 54.83%, while the Sensex has only fallen by 1.65%. <BR><BR>Despite today's performance indicating that the stock outperformed its sector by 1.52%, it is still lower than the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term downward trend. Additionally, the petrochemicals sector, in which Vikas Lifecare operates, has seen a decline of 3.02%. <BR><BR>On a more positive note, there has been a notable increase in investor participation, with delivery volume rising by 107% against the 5-day average. However, the overall negative trends in stock performance and sector movement contribute to the stock's current decline.

Why is Vikas Lifecare Ltd falling/rising?

As of 20-Mar, Vikas Lifecare Ltd's stock price is at Rs 1.29, reflecting a decline of 0.77%. The stock has significantly underperformed the Sensex, with a year-to-date drop of 27.12% and a 55.36% decrease over the past year, indicating a bearish trend.

As of 20-Mar, Vikas Lifecare Ltd's stock price is falling, currently at Rs 1.29, which reflects a decrease of Rs 0.01 or 0.77%. The stock has been underperforming significantly compared to the benchmark Sensex, showing a decline of 1.53% over the past week, and a substantial drop of 19.88% over the past month. Year-to-date, the stock has decreased by 27.12%, and over the past year, it has fallen by 55.36%, while the Sensex has only declined by 2.38% during the same period.<BR><BR>Additionally, the stock is trading lower than its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. It has also experienced consecutive losses for the last two days, with a total decline of 3.01% in that timeframe. Although there has been a rise in investor participation, with delivery volume increasing by 12.68% against the 5-day average, this has not translated into a positive price movement. The stock is also close to its 52-week low, being only 4.65% away from Rs 1.23. Overall, these factors contribute to the ongoing decline in Vikas Lifecare Ltd's stock price.

Why is Vikas Lifecare Ltd falling/rising?

As of 23-Mar, Vikas Lifecare Ltd's stock price is declining, currently at Rs. 1.22, reflecting a 5.43% drop and a new 52-week low. The stock has underperformed significantly compared to the Sensex over various time frames, with notable declines in investor participation and overall sector weakness contributing to its bearish trend.

As of 23-Mar, Vikas Lifecare Ltd's stock price is falling, currently at Rs. 1.22, which reflects a decrease of Rs. 0.07 or 5.43%. The stock has been on a downward trend, having lost value for the last three consecutive days, resulting in a total decline of 8.27% during this period. Additionally, the stock has reached a new 52-week low of Rs. 1.21 today.<BR><BR>In terms of performance relative to the broader market, Vikas Lifecare has underperformed significantly over various time frames. Over the past week, the stock has decreased by 3.17%, while the Sensex has fallen by a lesser 3.72%. Over the past month, the stock has dropped 22.78%, compared to a 12.72% decline in the Sensex. Year-to-date, the stock is down 31.07%, while the Sensex has only decreased by 14.70%. The one-year performance shows a stark contrast, with Vikas Lifecare down 58.08% against a modest 5.47% decline in the Sensex. Over three years, the stock has plummeted by 65.34%, while the Sensex has gained 25.50%. Similarly, over five years, Vikas Lifecare has decreased by 60.39%, while the Sensex has risen by 45.24%.<BR><BR>The stock is also trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Furthermore, there has been a notable decline in investor participation, with delivery volume dropping by 34.74% compared to the 5-day average. The overall sector, petrochemicals, has also seen a decline of 5.33%, contributing to the negative sentiment surrounding the stock.<BR><BR>In summary, the combination of consecutive price declines, poor performance relative to the market, low investor participation, and sector weakness are key factors contributing to the falling stock price of Vikas Lifecare Ltd.

Why is Vikas Lifecare Ltd falling/rising?

As of 24-Mar, Vikas Lifecare Ltd's stock price has risen slightly to Rs 1.23, but it remains significantly underperforming with a year-to-date decline of 30.51%. Despite today's increase, the stock is trading below all moving averages and has weak fundamentals, leading to a classification as a strong sell.

As of 24-Mar, Vikas Lifecare Ltd's stock price is rising slightly, with a current price of Rs 1.23, reflecting a change of 0.01 (0.82%) upward. This increase comes after three consecutive days of decline, indicating a potential trend reversal. However, the stock has been underperforming significantly in the longer term, with a year-to-date decline of 30.51% and a staggering 57.88% drop over the past year. <BR><BR>Despite today's rise, the stock is still trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a continued bearish trend overall. Additionally, the stock is close to its 52-week low, being only 1.63% away from Rs 1.21. <BR><BR>Investor participation has increased, with a delivery volume of 37.55 lacs on 23 March, which is 36.46% higher than the 5-day average. This could indicate some renewed interest from investors, but the overall fundamentals remain weak. The company has not declared results in the last six months, and its ability to service debt is concerning, as evidenced by a poor EBIT to Interest ratio of -0.77 and a low Return on Equity of 1.43%. <BR><BR>Moreover, the company reported negative results for the quarter ending June 25, with net sales falling by 23.0% and a significant drop in profit after tax of 56.2%. These factors contribute to the stock being classified as a strong sell, despite the minor rise observed today. Overall, while there is a slight uptick in price, the long-term outlook remains negative due to poor financial performance and market conditions.

Why is Vikas Lifecare Ltd falling/rising?

As of 25-Mar, Vikas Lifecare Ltd's stock is experiencing a short-term rise of 0.81%, following a two-day gain of 2.46%. However, long-term fundamentals remain weak, with a year-to-date decline of 29.94% and poor recent financial performance.

As of 25-Mar, Vikas Lifecare Ltd's stock price is currently rising, as indicated by a change of 0.01 (0.81%) increase. This uptick follows a trend where the stock has gained for the last two days, resulting in a total return of 2.46% during this period. Additionally, the stock has outperformed its sector by 1.45% today, which may be contributing to the positive sentiment among investors.<BR><BR>Despite this recent rise, the stock has shown significant underperformance over longer periods. For instance, it has declined by 29.94% year-to-date and 56.79% over the past year. The stock is also trading lower than its moving averages across various time frames, indicating a generally weak performance trend.<BR><BR>Investor participation appears to be increasing, with a delivery volume of 31.19 lacs on March 24, which is up by 15.44% compared to the five-day average. This suggests that more investors are willing to hold the stock, potentially providing some support for the recent price increase.<BR><BR>However, the overall outlook remains cautious due to the company's weak long-term fundamentals, including a negative EBIT to interest ratio of -0.77 and a low return on equity of 1.43%. The company has not declared results in the last six months, and recent financial performance has been poor, with net sales falling by 23.0% and a significant drop in profit after tax.<BR><BR>In summary, while Vikas Lifecare Ltd is experiencing a short-term rise in stock price, the long-term fundamentals and recent financial results indicate a challenging environment for the company.

Which are the latest news on Vikas Lifecare?